The aim of this study was to investigate the influence of red blood cell distribution width (RDW) on the long-term prognosis of percutaneous coronary intervention (PCI) for patients with non-ST-segment elevation acute coronary syndrome (NSTEACS). Methods: Two thousand one hundred and eighty-five NSTEACS cases with coronary artery disease and preoperative record of RDW who under went elective PCI treatment from July 2009 to September 2011 were selected. According to preoperative RDW levels, the patients were divided into two groups. One thousand one hundred and seventy cases belonged to the RDW < 12.2 group, 1015 cases belonged to RDW ≥ 12.2 group. The clinical characteristics and the incidence of postoperative mortality in the two groups were compared. There was a follow-up period of 540 days.
INTRODUCTION
Red blood cell distribution width (RDW) can reflect significantly various sizes of red blood cell volume when the mean corpuscular volume was still in the normal range. Therefore, RDW can reflect in vivo environmental changes and red blood cell proliferation changes sooner than haemoglobin and mean corpuscular volume. Red blood cell distribution width was used for clinical diagnosis and differential diagnosis of anaemia (1) . Studies have shown that increased RDW also could be used as a reflection of inflammation index (2) (3) (4) (5) .
Recent studies have shown that increased RDW was not only a predictor of a poor prognosis in heart failure (6, 7) , coronary artery disease (8) (9) (10) and pulmonary hypertension (11, 12) but also had predictive value for prognosis of patients with stable coronary artery disease undergoing percutaneous coronary intervention [PCI] (13, 14) . Currently, there are no studies about the impact of elevated RDW on the prognosis for NSTEACS patients undergoing PCI. This study aimed to investigate the effects of RDW on prognosis by analysing the clinical data and follow-up of NSTEACS patients undergoing PCI.
SUBJECTS AND METHODS Subjects
In this study, 2185 NSTEACS cases with coronary artery disease and preoperative record of RDW who had elective PCI treatment from July 2009 to September 2011, were selected. The demographic data, clinical features, laboratory tests, medications, coronary artery disease and revascularization information during hospitalization were recorded, and the clinic or telephone follow-ups were documented. According to the median of preoperative RDW (12.2%), the patients were divided into two groups (RDW < 12.2 group included 1170 cases, RDW ≥ 12.2 group included 1015 patients). The clinical characteristics and the incidence of postoperative mortality of the two groups were compared. This study was conducted in accordance with the Declaration of Helsinki. This study was conducted with approval from the Ethics Committee of Capital Medical University. Written informed consent was obtained from all participants.
Data processing
Raw data related to the research topic was collected from standard hospital medical history by researchers. The laboratory tests and echocardiographic data were the data on admission to hospital before the interventional procedure. The follow-up and input of all data were completed by cardiologists. The telephone follow-up was performed according to a pre-designed questionnaire, the follow-up data were filled into a unified form, then entered into the computer database.
Statistical analysis
Measurement data were expressed as a mean ± standard deviation. The measurement data between the two groups were compared using t-test. Enumeration data was compared using a Chi-squared test. The relevant factors affecting the overall mortality were statistically analysed by Cox regression equation. Cox regression analysis was performed to calculate the relative risk (HR) of all relevant factors and 95% confidence intervals (95% CI) using two-sided test. p < 0.05 was considered to be statistically significant. All data analysis was processed using SPSS13.0 statistical software.
RESULTS

General information
All enrolled 2185 patients comprised of 1170 cases with RDW < 12.2 and 1015 patients with RDW ≥ 12.2. The average follow-up duration was 540 days; the follow-up rate was 93.1%. Compared with the patients in the RDW < 12.2 group, the proportion of female patients in the RDW ≥ 12.2 group was large, and more patients had combination of hypertension and history of cerebrovascular disease, and the body mass index (BMI) was high at admission, the haemoglobin levels and total cholesterol levels were low. In addition, the patients in the RDW ≥ 12.2 group had high usage of β-blockers in the hospital. Multivessel coronary artery disease, the proportion of complete revascularization rate and other aspects had no sig-nificant difference between the patients in the two groups (Table 1) . ≥ 12.2 before PCI was still an independent predictor of mortality for the patients (HR 2.171, 95% CI 1.007, 4.680, p = 0.048, Table 2 ). Long-term survival of patients in the RDW ≥ 12.2 group was significantly lower than that of the patients in the RDW < 12.2 group (Fig. 1) . transcription, whose increase can lead to a lack of iron, thereby increasing RDW (15) . Interleukin-6 was a multifunctional cytokine and had an important role in the vascular injury of coronary heart disease, which had become an important marker of coronary atherosclerotic plaque stability. Interleukin-6 enhanced reactive protein and fibrinogen expression mainly through promoting platelet aggregation, as well as is involved in the inflammatory processes of plaque instability through adjusting the expression of other inflammatory factors (16) . Data analysis from the study of Third National Health and Nutrition Survey of the USA showed that C-reactive protein and fibrinogen levels were closely related to white blood cell count (WBC) and elevated RDW (17) . Lippi et al (4) found that the relationship between high RDW and elevated inflammatory markers was similar to the association between the erythrocyte sedimentation rate and C-reactive associated protein, and this relationship was independent of its concomitant diseases. After excluding the blood diseases, this relationship was also present. C-reactive protein is an independent risk factor for coronary artery disease, the elevated levels of C-reactive protein was positively correlated with the incidence of cardiovascular adverse events (18) (19) (20) . Therefore, the prediction of RDW on cardiovascular disease prognosis may reflect the prognosis of inflammation on cardiovascular disease.
The study was a single-center retrospective study. The presence of residual confounding factors may affect the results, in addition to the lack of serum iron, folic acid, vitamin B12 other indicators.
Accurate risk stratification and prognosis assessment were performed to patients with coronary artery disease to identify the high-risk groups, which was essential for clinicians. The detection for RDW was simple and easy without additional costs, so it has the potential to become a new indicator in the prognostic evaluation and risk stratification of the patients with coronary artery disease. 
DISCUSSION
The results of this study showed that in the NSTEACS patients undergoing PCI, the proportion with both hypertension and cerebrovascular disease for the patients in the RDW ≥ 12.2 group was high, and the postoperative mortality was 2.7 times of the patients in the RDW < 12.2 group. After adjusting for other factors, RDW ≥ 12.2 of the patients before PCI was an independent predictor of postoperative mortality (HR 2.171, 95% CI 1.007, 4.680, (p = 0.048). A similar conclusion was also found in the study on the patients with stable coronary artery disease. The study of Osadnik et al (13) included 2550 cases with stable coronary artery disease undergoing PCI; the subjects were divided into four groups according to the RDW level before grouping. After 2.5 years of follow-up, it was found that the mortality of the highest RDW group (≥ 14.1%) was four times (17.1% vs 4.3%, p < 0.0001) of that of the lowest group (< 13.1%). Tsuboi et al (14) studied 560 cases with stable coronary artery disease with diabetes mellitus undergoing PCI, and it was found in the 3.9 years of follow-up that the death rate of the increased value RDW group (13.3%, 14.2%) was 2.56 times (95% CI of 1.12, 6.62, p = 0.025) of that in the low-value RDW group (12.4%, 12.9%).
Increased RDW may be the overall performance of various potential adverse factors; RDW prognostic effect on cardiovascular disease may also be a variety of factors prognostic role on the external manifestation of cardiovascular disease. The exact mechanism of RDW related to the prognosis of cardiovascular disease was not clear. Studies have shown that elevated neutral/lymphocyte ratio was considered as an indicator directly reflecting inflammation, which had a high degree of correlation with the level of RDW, so RDW was considered as an inflammatory cytokine (2) . As a classic inflammatory cytokines, IL-6 Interleukin-6 was closely linked with elevated RDW (3). Interleukin-6 was a potent inducer for hepcidin gene
